JP2025504955A5 - - Google Patents
Info
- Publication number
- JP2025504955A5 JP2025504955A5 JP2024544969A JP2024544969A JP2025504955A5 JP 2025504955 A5 JP2025504955 A5 JP 2025504955A5 JP 2024544969 A JP2024544969 A JP 2024544969A JP 2024544969 A JP2024544969 A JP 2024544969A JP 2025504955 A5 JP2025504955 A5 JP 2025504955A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- amino acid
- acid sequence
- seq
- protein according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263305003P | 2022-01-31 | 2022-01-31 | |
| US63/305,003 | 2022-01-31 | ||
| US202263309759P | 2022-02-14 | 2022-02-14 | |
| US63/309,759 | 2022-02-14 | ||
| US202263342283P | 2022-05-16 | 2022-05-16 | |
| US63/342,283 | 2022-05-16 | ||
| US202263348842P | 2022-06-03 | 2022-06-03 | |
| US63/348,842 | 2022-06-03 | ||
| PCT/EP2023/052366 WO2023144423A1 (en) | 2022-01-31 | 2023-01-31 | Activatable bispecific anti-cd47 and anti-pd-l1 proteins and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025504955A JP2025504955A (ja) | 2025-02-19 |
| JP2025504955A5 true JP2025504955A5 (https=) | 2026-02-06 |
Family
ID=85199086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024544969A Pending JP2025504955A (ja) | 2022-01-31 | 2023-01-31 | 活性化可能な二重特異的抗ｃｄ４７および抗ｐｄ－ｌ１タンパク質ならびにその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250002585A1 (https=) |
| EP (1) | EP4473012A1 (https=) |
| JP (1) | JP2025504955A (https=) |
| KR (1) | KR20240137084A (https=) |
| AU (1) | AU2023210844A1 (https=) |
| CA (1) | CA3251615A1 (https=) |
| IL (1) | IL314395A (https=) |
| MX (1) | MX2024009251A (https=) |
| WO (1) | WO2023144423A1 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1907424E (pt) | 2005-07-01 | 2015-10-09 | Squibb & Sons Llc | Anticorpos monoclonais humanos para o ligando 1 de morte programada (pd-l1) |
| CN111212852A (zh) | 2017-08-18 | 2020-05-29 | 超人肆有限公司 | 结合剂 |
| US20240124889A1 (en) * | 2019-05-07 | 2024-04-18 | Voyager Therapeutics, Inc. | Compositions and methods for the vectored augmentation of protein destruction, expression and/or regulation |
| GB201906685D0 (en) * | 2019-05-13 | 2019-06-26 | Ultrahuman Six Ltd | Activatable protein constructs and uses thereof |
| CN116390939A (zh) * | 2020-08-04 | 2023-07-04 | 埃克塞里艾克西斯公司 | 多重特异性结合剂及其用途 |
-
2023
- 2023-01-31 CA CA3251615A patent/CA3251615A1/en active Pending
- 2023-01-31 AU AU2023210844A patent/AU2023210844A1/en active Pending
- 2023-01-31 IL IL314395A patent/IL314395A/en unknown
- 2023-01-31 EP EP23703706.4A patent/EP4473012A1/en active Pending
- 2023-01-31 MX MX2024009251A patent/MX2024009251A/es unknown
- 2023-01-31 WO PCT/EP2023/052366 patent/WO2023144423A1/en not_active Ceased
- 2023-01-31 KR KR1020247028692A patent/KR20240137084A/ko active Pending
- 2023-01-31 JP JP2024544969A patent/JP2025504955A/ja active Pending
-
2024
- 2024-07-19 US US18/778,061 patent/US20250002585A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2801873T3 (es) | Anticuerpo de PDL-1, composición farmacéutica del mismo y sus usos | |
| CN110914306B (zh) | 检查点抑制物双特异性抗体 | |
| CN107921122B (zh) | 与cd38结合的抗体治疗剂 | |
| TWI708788B (zh) | 雙特異性抗體 | |
| CN113874399B (zh) | 抗ror1/抗cd3双特异性结合分子 | |
| JP7734753B2 (ja) | 抗ｃｌｄｎ６抗体およびその使用 | |
| AU2014266118B2 (en) | Antibody specifically binding to HER2 | |
| CN116731180A (zh) | 抗ror1抗体及其制备和使用方法 | |
| Chen et al. | A bispecific antibody targeting HER2 and PD-L1 inhibits tumor growth with superior efficacy | |
| JP2021515541A5 (https=) | ||
| JP7675818B2 (ja) | 抗クローディン－１８．２抗体及びその抗体薬物複合体 | |
| JP2022550243A (ja) | 抗ｐｄ－１抗体及びその使用 | |
| JP2021515542A5 (https=) | ||
| JP2024538669A5 (https=) | ||
| JP2023518153A5 (https=) | ||
| JP2024540148A5 (https=) | ||
| JP2022532991A5 (https=) | ||
| JP2022553908A5 (https=) | ||
| JP2025511289A5 (https=) | ||
| JP2024542192A5 (https=) | ||
| JP2024534795A (ja) | 二重特異性抗体およびその使用 | |
| JP7738914B2 (ja) | ＴｒｉＡｘ抗体の組成、その製造方法及び使用方法 | |
| JP2021515544A5 (https=) | ||
| CN115038497A (zh) | TGF-β-RII结合蛋白质 | |
| JP2025511002A5 (https=) |